Recursion ex-director plans sale of 75K shares
RECURSION PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RECURSION PHARMACEUTICALS, INC. (RXRX) received a Rule 144 notice covering planned sales of 75,000 Class A shares held for the account of former director Christopher C. Gibson. The shares are held at Fidelity Brokerage Services LLC, with an aggregate market value of $255,000.00 and are listed on NASDAQ. The notice also details extensive Class A share sales during the prior three months by Gibson, Lahwran-3 LLC, and the Gibson Family Trust, entities for which Gibson is an authorized individual, trustee, or account stakeholder.
Key Figures
Key Terms
Rule 144 regulatory
attorney-in-fact regulatory
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for RECURSION PHARMACEUTICALS, INC. (RXRX)?
Who is the selling security holder in the RXRX Form 144 and what is his role?
AI-generated analysis. How Rhea-AI works. Not financial advice.